100 related articles for article (PubMed ID: 8535219)
1. All-trans retinoic acid in the treatment of myelodysplastic syndromes.
Visani G; Tosi P; Manfroi S; Ottaviani E; Finelli C; Cenacchi A; Bendandi M; Tura S
Leuk Lymphoma; 1995 Oct; 19(3-4):277-80. PubMed ID: 8535219
[TBL] [Abstract][Full Text] [Related]
2. All-trans retinoic acid in patients with myelodysplastic syndromes: results of a pilot study.
Aul C; Runde V; Gattermann N
Blood; 1993 Nov; 82(10):2967-74. PubMed ID: 8219188
[TBL] [Abstract][Full Text] [Related]
3. Treatment of myelodysplastic syndromes with all-trans retinoic acid. Leukemia Study Group of the Ministry of Health and Welfare.
Ohno R; Naoe T; Hirano M; Kobayashi M; Hirai H; Tubaki K; Oh H
Blood; 1993 Mar; 81(5):1152-4. PubMed ID: 8443376
[TBL] [Abstract][Full Text] [Related]
4. [Retrospective observation of curative effects on MDS refractory anemia with combination of all-trans retinoic acid, 1, 25-dihydroxyvitamin D3 and androgen].
Zhou FL; Zhang WG; Cao XM; Chen YX; He AL; Liu J; Zhao WH; Ma XR; Chen G
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):861-6. PubMed ID: 16277859
[TBL] [Abstract][Full Text] [Related]
5. Improved multilineage response of hematopoiesis in patients with myelodysplastic syndromes to a combination therapy with all-trans-retinoic acid, granulocyte colony-stimulating factor, erythropoietin and alpha-tocopherol.
Ganser A; Maurer A; Contzen C; Seipelt G; Ottmann OG; Schadeck-Gressel C; Kolbe K; Haas R; Zander C; Reutzel R; Hoelzer D
Ann Hematol; 1996 Apr; 72(4):237-44. PubMed ID: 8624378
[TBL] [Abstract][Full Text] [Related]
6. [Low dose all-trans retinoic acid and androgen therapy for patients with myelodysplastic syndrome].
Guan M; Chen SC; Li RS; Ge CW; Zhu HL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):774-8. PubMed ID: 15631659
[TBL] [Abstract][Full Text] [Related]
7. Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor.
Hofmann WK; Ganser A; Seipelt G; Ottmann OG; Zander C; Geissler G; Hoffmann K; Höffken K; Fischer JT; Isele G; Hoelzer D
Ann Hematol; 1999 Mar; 78(3):125-30. PubMed ID: 10211754
[TBL] [Abstract][Full Text] [Related]
8. Effect of combination therapy with all-trans-retinoic acid and recombinant human granulocyte colony-stimulating factor in patients with myelodysplastic syndromes.
Ganser A; Seipelt G; Verbeek W; Ottmann OG; Maurer A; Kolbe K; Hess U; Elsner S; Reutzel R; Wörmann B
Leukemia; 1994 Mar; 8(3):369-75. PubMed ID: 7510354
[TBL] [Abstract][Full Text] [Related]
9. Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia.
Kuendgen A; Knipp S; Fox F; Strupp C; Hildebrandt B; Steidl C; Germing U; Haas R; Gattermann N
Ann Hematol; 2005 Dec; 84 Suppl 1():61-6. PubMed ID: 16270213
[TBL] [Abstract][Full Text] [Related]
10. 13-cis-Retinoic acid treatment in patients with myelodysplastic syndrome.
Leoni F; Ciolli S; Longo G; Messori A; Ferrini PR
Acta Haematol; 1988; 80(1):8-12. PubMed ID: 3135696
[TBL] [Abstract][Full Text] [Related]
11. A phase-II trial of all trans retinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromes.
Venditti A; Tamburini A; Buccisano F; Scimò MT; Del Poeta G; Maurillo L; Cox MC; Abruzzese E; Tribalto M; Masi M; Amadori S
Ann Hematol; 2000 Mar; 79(3):138-42. PubMed ID: 10803936
[TBL] [Abstract][Full Text] [Related]
12. Increase in platelet count in older, poor-risk patients with acute myeloid leukemia or myelodysplastic syndrome treated with valproic acid and all-trans retinoic acid.
Pilatrino C; Cilloni D; Messa E; Morotti A; Giugliano E; Pautasso M; Familiari U; Cappia S; Pelicci PG; Lo Coco F; Saglio G; Guerrasio A
Cancer; 2005 Jul; 104(1):101-9. PubMed ID: 15895376
[TBL] [Abstract][Full Text] [Related]
13. [Long-term effects of androgen combined with low dose all-trans-retinoic acid on myelodysplastic syndrome: follow-up of 60 cases].
Guan M; Chen SC; Ge CW
Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):919-22. PubMed ID: 19671296
[TBL] [Abstract][Full Text] [Related]
14. [Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes].
García Marco J; Miguel Sosa A; García Conde J; Miguel García A; Arbona C; Escrig V; Benet I; Navarro I; Ruiz A; Carbonell F
Sangre (Barc); 1994 Aug; 39(4):241-4. PubMed ID: 7985051
[TBL] [Abstract][Full Text] [Related]
15. Changes in erythroid progenitor cell and accessory cell compartments in patients with myelodysplastic syndromes during treatment with all-trans retinoic acid and haemopoietic growth factors.
Maurer AB; Ganser A; Seipelt G; Ottmann OG; Mentzel U; Geissler GR; Hoelzer D
Br J Haematol; 1995 Mar; 89(3):449-56. PubMed ID: 7537524
[TBL] [Abstract][Full Text] [Related]
16. Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 cases.
Itzykson R; Ayari S; Vassilief D; Berger E; Slama B; Vey N; Suarez F; Beyne-Rauzy O; Guerci A; Cheze S; Thomas X; Stamatoullas A; Gardembas M; Bauduer F; Kolb A; Chaury MC; Legros L; Damaj G; Chermat F; Dreyfus F; Fenaux P; Ades L;
Leukemia; 2009 Apr; 23(4):673-8. PubMed ID: 19151787
[TBL] [Abstract][Full Text] [Related]
17. Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study.
Hofmann WK; Kell WJ; Fenaux P; Castaigne S; Ganser A; Chomienne C; Burnett R; Kowal C; Hoelzer D; Burnett AK
Leukemia; 2000 Sep; 14(9):1583-8. PubMed ID: 10995004
[TBL] [Abstract][Full Text] [Related]
18. Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid.
Kuendgen A; Strupp C; Aivado M; Bernhardt A; Hildebrandt B; Haas R; Germing U; Gattermann N
Blood; 2004 Sep; 104(5):1266-9. PubMed ID: 15155466
[TBL] [Abstract][Full Text] [Related]
19. Differentiation therapy of myelodysplastic syndromes with retinoic acid.
Ohno R
Leuk Lymphoma; 1994 Aug; 14(5-6):401-9. PubMed ID: 7812199
[TBL] [Abstract][Full Text] [Related]
20. Combination of low-dose cytarabine and 13-cis retinoic acid in the treatment of myelodysplastic syndromes.
Ho AD; Martin H; Knauf W; Reichardt P; Trümper L; Hunstein W
Leuk Res; 1987; 11(11):1041-4. PubMed ID: 3320577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
